Salepage link: At HERE. Archive:
n
n

DOWNLOAD INSTANTLYnPLEASE CHECK ALL CONTENTS OF THE COURSE BELOW!

n

n

n

Sharon Tang – Pharmacy Practice June 2017

nn

nn

Pharmacy Practice June 2017

n

Scroll down to preview some questions and answers!

nTutorial going through the Pharmacy Practice June 2017 past paper.n

Your Instructor

n nnSharon TangnnStarted this online tutorial platform in September 2017. I have a BPharm (1996) and a PhD in Pharmacognosy (2003) obtained from the University of London School of Pharmacy and have worked in community and in hospital in the UK. Since moving to Hong Kong several years ago I have passed the registration exams (2012). I have also taught pharmacology and human disease topics to pharmacy technicians and student nurses, which included writing exams and marking them. The Facebook group I run provides support for pharmacists taking the Hong Kong pharmacy registration exams.n

Course Curriculum

nPharmacy Practice June 2017nIntroductionnnIntroductionnnQuestion 1A – Calculations: rate of administration, ratios, molarity and osmolalitynnQuestion 1A – Rate of administration, molarity and osmolalitynnAnswernnQuestion 1B – Calculations: dilution, rate of administrationnnQuestion 1B – dilution and equivalentsnnAnswernnQuestion 1C – Calculations: dilution, ratio, rate of administrationnnQuestion 1CnnAnswernnQuestion 1D – Half life calculationnnQuestion 1D – Vancomycin and half lifennAnswernnQuestion 2 – Statins and ASCVDnnQuestion – Statins and ASCVDnnAnswer part a) – Risk factors for ASCVD and lifestyle modificationsnnAnswer part b) – Statins, prescribing guidelines and safetynnAnswer part c) – Statin alternativesnnQuestion 3 – Drug administration via enteral feeding tubesnnQuestion 3 – Drug administration via enteral feeding tubesnnAnswernnQuestion 4 – Sofosbuvir and Ribavirin and treatment of Hepatitis CnnQuestion 4 – Sofosbuvir and Ribavirin for Hepatitis CnnAnswer part a) – Information prior to dispensingnnAnswer part b) – Common adverse effectsnnAnswer part c) – MonitoringnnAnswer part d) – Alternatives to ribavirinnnQuestion 5 – Solubility: pharmaceutical salts, cyclodextrin and surfactantsnnQuestion 5 – Solubility: pharmaceutical salts, cyclodextrin and surfactantsnnAnswer part a) – Pharmaceutical saltsnnAnswer part b) – CyclodextrinnnAnswer part c) – Surfactantsnn

nnSales PagenArchive Pagenn